Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results.
Comi G; O'Connor P; Montalban X; Antel J; Radue EW; Karlsson G; Pohlmann H; Aradhye S; Kappos L; Multiple Sclerosis (Houndmills, Basingstoke, England), 2010, vol. 16, issue 2, p 197, ISSN 14770970. ISBN 14770970.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef